Holen Sie sich die Stockscreener-App
8.00
7.82%
0.58
Handel nachbörslich:
8.27
0.27
+3.37%
Schlusskurs vom Vortag:
$7.42
Offen:
$7.43
24-Stunden-Volumen:
9.49M
Relative Volume:
4.74
Marktkapitalisierung:
$974.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.07M
KGV:
-27.59
EPS:
-0.29
Netto-Cashflow:
$-31.85M
1W Leistung:
+7.82%
1M Leistung:
+1.65%
6M Leistung:
+77.78%
1J Leistung:
+174.91%
1-Tages-Spanne:
$7.37
$8.78
1-Wochen-Bereich:
$7.23
$8.78
52-Wochen-Spanne:
$2.36
$8.78
Trevi Therapeutics Inc Stock (TRVI) Company Profile
Firmenname
Trevi Therapeutics Inc
Sektor
Branche
Telefon
203-304-2499
Adresse
195 CHURCH STREET, NEW HAVEN, CT
Vergleichen Sie TRVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
8.00 | 903.58M | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Trevi Therapeutics Inc Stock (TRVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-07-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-05-28 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-10 | Bestätigt | Needham | Buy |
| 2025-03-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-30 | Eingeleitet | Raymond James | Outperform |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-04-12 | Eingeleitet | B. Riley Securities | Buy |
| 2022-11-22 | Eingeleitet | SVB Leerink | Outperform |
| 2019-06-03 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-06-03 | Eingeleitet | Needham | Buy |
| 2019-06-03 | Eingeleitet | SVB Leerink | Outperform |
| 2019-06-03 | Eingeleitet | Stifel | Buy |
Alle ansehen
Trevi Therapeutics Inc Aktie (TRVI) Neueste Nachrichten
Why Trevi Therapeutics Inc. is moving todayBull Run & Fast Momentum Entry Tips - Newser
Will Trevi Therapeutics Inc. stock go up soonEarnings Beat & Reliable Trade Execution Plans - Newser
What Fibonacci levels say about Trevi Therapeutics Inc. reboundJuly 2025 Highlights & Community Supported Trade Ideas - Newser
Tools to assess Trevi Therapeutics Inc.’s risk profileWatch List & Daily Market Momentum Tracking - Newser
What data driven models say about Trevi Therapeutics Inc.’s futureQuarterly Market Summary & High Return Stock Watch Alerts - Newser
Multi asset correlation models including Trevi Therapeutics Inc.2025 Technical Patterns & Weekly Return Optimization Plans - Newser
Trevi stock up as B. Riley cites deal prospects (TRVI:NASDAQ) - Seeking Alpha
Trevi Therapeutics (TRVI.O) Sees Sharp Intraday Move — But No Clear Technical Signal, So What's Driving It? - AInvest
What to expect from Trevi Therapeutics Inc. in the next 30 daysQuarterly Trade Summary & Capital Efficiency Focused Ideas - Newser
Statistical indicators supporting Trevi Therapeutics Inc.’s strengthJuly 2025 Earnings & Fast Entry and Exit Trade Plans - Newser
Tick level data insight on Trevi Therapeutics Inc. volatility2025 EndofYear Setup & Free High Return Stock Watch Alerts - Newser
Will Trevi Therapeutics Inc. price bounce be sustainable2025 Market Trends & Community Supported Trade Ideas - Newser
What’s next for Trevi Therapeutics Inc. stock priceQuarterly Performance Summary & Daily Chart Pattern Signals - Newser
Volatility clustering patterns for Trevi Therapeutics Inc.July 2025 Update & AI Forecast Swing Trade Picks - Newser
Trevi Therapeutics Inc. stock trendline breakdownMarket Risk Report & Weekly High Return Stock Opportunities - Newser
Can volume confirm reversal in Trevi Therapeutics Inc.Gold Moves & Weekly Chart Analysis and Guides - Newser
Applying chart zones and confluence areas to Trevi Therapeutics Inc.Market Movement Recap & Free Weekly Watchlist of Top Performers - Newser
How institutional ownership impacts Trevi Therapeutics Inc. stockWeekly Trade Analysis & Scalable Portfolio Growth Ideas - Newser
Published on: 2025-08-26 09:21:24 - Newser
Has Trevi Therapeutics Inc. found a price floor2025 Trading Recap & Risk Controlled Swing Alerts - Newser
Key metrics from Trevi Therapeutics Inc.’s quarterly dataWeekly Profit Report & Verified Entry Point Detection - Newser
Market reaction to Trevi Therapeutics Inc.’s recent newsJuly 2025 Closing Moves & High Accuracy Trade Alerts - Newser
Using Ichimoku Cloud for Trevi Therapeutics Inc. technicalsBull Run & Risk Managed Trade Strategies - Newser
Using data tools to time your Trevi Therapeutics Inc. exitEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - Newser
Published on: 2025-08-25 02:43:15 - Newser
Breakout Zone: Can Trevi Therapeutics Inc. outperform in the next rallyCEO Change & Smart Swing Trading Techniques - sundaytimes.kr
Can Trevi Therapeutics Inc. rally from current levelsEarnings Summary Report & Free Community Consensus Stock Picks - Newser
Trend analysis for Trevi Therapeutics Inc. this weekQuarterly Trade Report & Community Verified Swing Trade Signals - Newser
Real time breakdown of Trevi Therapeutics Inc. stock performance2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - Newser
Can Trevi Therapeutics Inc. hit a new high this month2025 Market WrapUp & High Accuracy Swing Entry Alerts - Newser
Can Trevi Therapeutics Inc. Overcome Bearish SentimentJuly 2025 Institutional & Growth Oriented Trading Recommendations - 더경남뉴스
Trevi Therapeutics - Hartford Business Journal
CFO at CT bioscience company to step down - Hartford Business Journal
Morgan Stanley Initiates Trevi Therapeutics at Overweight - MarketScreener
Trevi Therapeutics CFO Resignation Announced - TipRanks
Trevi Therapeutics CFO Lisa Delfini to resign on August 22. - AInvest
Trevi Therapeutics says Lisa Delfini to resign as CFO on Aug 22 - MarketScreener
Trevi Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective August 22, 2025 - MarketScreener
Trevi Therapeutics Inc. Added to Custom Quant Screener TodayMarket Sentiment Report & High Accuracy Trade Signal Alerts - thegnnews.com
Published on: 2025-08-20 00:30:25 - Newser
Developing predictive dashboards with Trevi Therapeutics Inc. dataMarket Volume Summary & AI Driven Stock Movement Reports - Newser
Detecting support and resistance levels for Trevi Therapeutics Inc.Weekly Trade Review & Detailed Earnings Play Alerts - Newser
Chart based exit strategy for Trevi Therapeutics Inc.Weekly Trading Summary & Community Verified Trade Signals - Newser
Can Trevi Therapeutics Inc. outperform in the next rallyQuarterly Risk Review & Weekly Breakout Opportunity Watchlist - thegnnews.com
Finanzdaten der Trevi Therapeutics Inc-Aktie (TRVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):